4.5 Article

Expression and purification of an influenza hemagglutinin - one step closer to a recombinant protein-based influenza vaccine

期刊

VACCINE
卷 24, 期 12, 页码 2176-2185

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2005.11.005

关键词

influenza; vaccine; hemagglutinin; baculovirus; recombinant protein; purification; chromatography

向作者/读者索取更多资源

Numerous human infections with avian influenza viruses in Asia in recent years have raised the concern that the next influenza pandemic is imminent. The most effective way to combat influenza is through the vaccination of the public. However, a minimum of 3-6 months is needed to develop an influenza vaccine using the traditional egg-based vaccine approach. The influenza hemagglutinin protein (HA), the active ingredient in the current vaccine, can be expressed in insect cells using the baculovirus expression vector system and purified rapidly. An influenza vaccine based on such a recombinant antigen allows a more timely response to a potential influenza pandemic. Here, we report an innovative monitoring assay for recombinant HA (rHA) expression and a rapid purification process. Various biochemical analyses indicate that the purified rHA is properly folded and biologically active. (c) 2005 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据